J Cancer 2021; 12(21):6497. doi:10.7150/jca.32930

Erratum

High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum

Ming Cui1, Lei You1, Bang Zheng2, Xinmei Huang3,4, Qiaofei Liu1, Jing Huang3,4, Boju Pan5, Xiaoyan Qiu3,4✉, Quan Liao1✉, Yupei Zhao1✉

1. Department of General Surgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China
2. School of Public Health, Faculty of Medicine, Imperial College London, London W6 8RP, UK
3. Department of Immunology, School of Basic Medical Sciences, Peking University, Beijing 100191, China
4. Peking University Center for Human Disease Genomics, Beijing 100191, China
5. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Citation:
Cui M, You L, Zheng B, Huang X, Liu Q, Huang J, Pan B, Qiu X, Liao Q, Zhao Y. High Expression of Cancer-Derived Glycosylated Immunoglobulin G Predicts Poor Prognosis in Pancreatic Ductal Adenocarcinoma: Erratum. J Cancer 2021; 12(21):6497. doi:10.7150/jca.32930. Available from https://www.jcancer.org/v12p6497.htm

File import instruction

Corrected-article in J Cancer, Volume 11, 2213